Mylan gets EU approval for Meda purchase, subject to conditions

BRUSSELS, July 20 (Reuters) - EU antitrust regulators said

on Wednesday they had cleared generic drugmaker Mylan's

planned cash-and-stock purchase of Sweden's Meda

subject to it selling certain...

Read more